Meta-analysis of Long-Term Relapse Rate of Type 2 Diabetes Following Initial Remission After Roux-en-Y Gastric Bypass

Obes Surg. 2021 Nov;31(11):5034-5043. doi: 10.1007/s11695-021-05692-4. Epub 2021 Sep 10.

Abstract

This study aims to determine the long-term relapse rate of type 2 diabetes (T2DM) following initial remission after Roux-en-Y gastric bypass (RYGB) surgery. We searched studies in PubMed, Embase, and the Cochrane Library. A total of 17 eligible studies were included for analysis. Meta-analysis suggested a pooled long-term relapse rate of 0.30 (95% confidence interval [CI], 0.26-0.34) and a remission rate of 0.63 (95% CI, 0.55-0.72) after RYGB and a hazard ratio of 0.73 (95% CI, 0.66-0.81) for comparison of RYGB and sleeve gastrectomy (SG). Subgroup analyses established pooled results. This study suggested RYGB may be a preferred regime for obese patients with T2DM because it is associated with lower long-term relapse and relatively higher initial remission and was also superior to SG due to lower risk of recurrence.

Keywords: Bariatric surgery; Meta-analysis; Roux-en-Y gastric bypass; Sleeve gastrectomy; Type 2 diabetes.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Diabetes Mellitus, Type 2* / surgery
  • Gastrectomy
  • Gastric Bypass*
  • Humans
  • Obesity, Morbid* / surgery
  • Recurrence
  • Treatment Outcome